Paroxysmal Nocturnal Hemoglobinuria (PNH) confirmatory test is a specialized diagnostic test used to detect abnormal blood cells lacking protective surface proteins, which makes them vulnerable to destruction by the immune system. This rare condition can lead to anemia, blood clots, and organ damage. The test is performed to confirm the presence of PNH by identifying these defective cells, helping doctors establish an accurate diagnosis and guide appropriate treatment for patients with suspected PNH.
It helps establish a definitive diagnosis, guiding doctors to provide appropriate treatment and monitor complications like anemia, blood clots, and organ damage.
Patients with unexplained anemia, recurrent blood clots, or hemoglobin in urine are often recommended to undergo this test.
Yes, flow cytometry can detect even small populations of abnormal cells, making it useful for early diagnosis.
Yes, it helps track disease progression and response to therapies like eculizumab or ravulizumab.
Routine tests may show anemia, but only specialized confirmatory tests can diagnose PNH accurately.
PNH is acquired, not inherited, so genetic testing is not typically required for diagnosis.
Yes, it specifically identifies defective cells, distinguishing PNH from other causes of anemia.
Yes, though rare in children, the test can be performed safely when symptoms suggest PNH.
Doctors confirm PNH and discuss treatment options, including supportive care and targeted therapies.
...
Didn't recieved OTP Yet? Resend OTP